Page 196 - Immunization Practices News Today

Americas break from influenza may be at and end. What can be expected as fall approaches?

Americans will soon have an alternative to the mRNA-based shots from Pfizer-BioNTech and Moderna with the Food and Drug Administration (FDA) authorizing Novavax's protein-based COVID vaccine for adults.

Alabama and Mississippi are among states expecting few young children will get the shots soon.

(CNN) — The US Food and Drug Administration on Wednesday authorized Novavax’s COVID-19 vaccine for emergency use in adults. It is the fourth coronavirus vaccine available in the United States, and it uses a different type of vaccine technology than the shots already available. Novavax’s vaccine will be available as two-dose primary series for people […]

Executives have said they hope the shot will see uptake in individuals who have expressed hesitancy toward other Covid-19 vaccines or are allergic to components of the others' ingredients.

The US Food and Drug Administration (FDA) on Wednesday issued an emergency use authorization (EUA) for the Novavax COVID-19 vaccine in individuals 18 years of age and older.

States where parents have hesitated to inoculate their children against Covid-19 are now ordering fewer vaccine doses for children under 5 than others.

The US Food and Drug Administration on Wednesday authorized Novavaxs Covid-19 vaccine for emergency use in adults. It is the fourth coronavirus vaccine available in the United States, and it

The U.S. Food and Drug Administration on Wednesday authorized Novavaxs COVID-19 vaccine for emergency use in adults. It is the fourth coronavirus vaccine available in the United States, and it uses a different type of vaccine technology than the shots already available.

It is a protein-based vaccine, and such vaccines use harmless protein fragments of the virus to teach the immune system how to spot the virus and fight it off.